Increasing Incidence of Osteoarthritis and Osteoporosis Driving Collagen Peptide Market, Finds Frost & Sullivan PR Newswire MOUNTAIN VIEW, California, June 26, 2012 - Market propelled further by manufacturers investing on research and development to prove product efficacy MOUNTAIN VIEW, California, June 26, 2012 /PRNewswire/ -- One of the main challenges faced by the collagen peptide industry is fierce competition from established ingredients like chondroitin sulfate and glucosamine. Manufacturers, however, are combating this situation by conducting numerous studies in order to prove the efficacy of collagen peptides and show the benefits of combining peptides with other ingredients. New analysis from Frost & Sullivan (http://www.food.frost.com), Strategic Analysis of the Collagen Peptide Market in the United States, finds that the market earned revenues of $224.6 million in 2011. It is expected to increase to $344.5 million by 2017. If you are interested in more information on this research, please send an email to Jeannette Garcia, Corporate Communications, at jeannette.garcia@frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. The increasing incidence of osteoporosis and osteoarthritis, combined with an aging population globally, promises a great growth potential for collagen peptides.